[go: up one dir, main page]

MXPA01011721A - Methods for predicting and/or diagnosing the risk of gastric cancer. - Google Patents

Methods for predicting and/or diagnosing the risk of gastric cancer.

Info

Publication number
MXPA01011721A
MXPA01011721A MXPA01011721A MXPA01011721A MXPA01011721A MX PA01011721 A MXPA01011721 A MX PA01011721A MX PA01011721 A MXPA01011721 A MX PA01011721A MX PA01011721 A MXPA01011721 A MX PA01011721A MX PA01011721 A MXPA01011721 A MX PA01011721A
Authority
MX
Mexico
Prior art keywords
diagnosing
predicting
risk
methods
gastric cancer
Prior art date
Application number
MXPA01011721A
Other languages
Spanish (es)
Inventor
Robert Llewellyn Clancy
Original Assignee
Onco Alert Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onco Alert Pty Ltd filed Critical Onco Alert Pty Ltd
Publication of MXPA01011721A publication Critical patent/MXPA01011721A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57446Specifically defined cancers of stomach or intestine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5406IL-4
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/555Interferons [IFN]
    • G01N2333/57IFN-gamma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
MXPA01011721A 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer. MXPA01011721A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer
PCT/AU2000/000441 WO2000070348A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer

Publications (1)

Publication Number Publication Date
MXPA01011721A true MXPA01011721A (en) 2003-09-10

Family

ID=3814581

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01011721A MXPA01011721A (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer.

Country Status (10)

Country Link
EP (1) EP1183540A4 (en)
JP (1) JP2002544520A (en)
KR (1) KR20020033093A (en)
CN (1) CN1355885A (en)
AU (1) AUPQ037799A0 (en)
BR (1) BR0010558A (en)
CA (1) CA2372761A1 (en)
HK (1) HK1044988A1 (en)
MX (1) MXPA01011721A (en)
WO (1) WO2000070348A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
CN103814295B (en) * 2011-09-14 2016-08-24 巴斯夫欧洲公司 Means and Methods for Assessing Nephrotoxicity
JP6707248B2 (en) * 2013-12-05 2020-06-10 学校法人北里研究所 Gastric cancer cell detection method and gastric cancer cell detection kit
RU2706118C1 (en) * 2019-04-30 2019-11-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Method for prediction of precancer diseases of stomach
CN115537465A (en) * 2022-02-28 2022-12-30 陈芳芳 Application of SCTAG in early warning and targeted drugs of gastric cancer
CN117143234B (en) * 2023-08-29 2024-05-03 武汉爱博泰克生物科技有限公司 Monoclonal antibody against rat interleukin-4 protein and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3814395A (en) * 1994-10-20 1996-05-15 Genelabs Diagnostics Pte Ltd Helicobacter pylori diagnostic methods and kits
IT1289578B1 (en) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa IMMUNOPURIFICATION OF AN ANTIGEN WITH AN APPARENT MOLECULAR WEIGHT OF 16 + - 2 KDA OF THE HELICOBACTER PYLORI AND METHODS FOR ITS

Also Published As

Publication number Publication date
EP1183540A4 (en) 2007-07-04
KR20020033093A (en) 2002-05-04
CN1355885A (en) 2002-06-26
JP2002544520A (en) 2002-12-24
AUPQ037799A0 (en) 1999-06-10
HK1044988A1 (en) 2002-11-08
BR0010558A (en) 2002-02-19
CA2372761A1 (en) 2000-11-23
EP1183540A1 (en) 2002-03-06
WO2000070348A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
HUP9904631A3 (en) Fine-grained caoutchouc-powders, procedure for making them and the use thereof
ZA99452B (en) Antibodies against human IL-12.
DE60026352D1 (en) Biosensor
GC0000080A (en) Wellbore system.
AU5270600A (en) The maize rs324 promoter and methods for use thereof
AU1465801A (en) Methods for cancer prognosis and diagnosis
ZA992470B (en) Automobile lining.
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
GB2353581B (en) Swage lining
MXPA01011721A (en) Methods for predicting and/or diagnosing the risk of gastric cancer.
ZA995694B (en) Open cast mining apparatus.
ZA200004279B (en) Method and device for the measurement of antenna impedance.
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
AU1700700A (en) Compounds, antibodies and methods for treating, preventing or diagnosing tumour metastasis
AU3429300A (en) Means for diagnosing and treating carcinoma
IL159975A0 (en) Stain-directed molecular analysis for cancer prognosis and diagnosis
AU2003294272A8 (en) Methods for diagnosing the presence or stage of cancer
ZA200000390B (en) Door closer.
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
IL160242A0 (en) Methods for the treatment and prognosis of leukemia and other cancer types
TR199900070A3 (en) The process for the preparation of naphthyrides and interconnects.
SI1157041T1 (en) Antibodies for cancer therapy and diagnosis
TW397218U (en) Mercurial thermo-switch
AU2002309668A1 (en) Methods for determining the prognosis for cancer patients using tucan
GB9803439D0 (en) The releasable door restraint